MAP2K4 and breast carcinoma: MAP3K1 acts upstream of MAP2K4 in signaling and in the METABRIC breast cancer study, loss-of-function mutations in these genes is mutually exclusive (p < 0.001) (Supplementary information, Fig. S1a).